(VIANEWS) – The Market ended the session with AFFLUENT MEDICAL (AFME.PA) rising 14.38% to €1.83 on Tuesday while CAC 40 rose 0.84% to €8,087.48.
AFFLUENT MEDICAL’s last close was €1.60, 30.43% under its 52-week high of €2.30.
About AFFLUENT MEDICAL
Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. The company was founded in 2011 and is based in Aix-en-Provence, France.
Earnings Per Share
As for profitability, AFFLUENT MEDICAL has a trailing twelve months EPS of €-0.65.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.37%.
Volatility
AFFLUENT MEDICAL’s last week, last month’s, and last quarter’s current intraday variation average was 1.31%, 0.17%, and 4.42%.
AFFLUENT MEDICAL’s highest amplitude of average volatility was 2.87% (last week), 5.22% (last month), and 4.42% (last quarter).
Moving Average
AFFLUENT MEDICAL’s worth is way higher than its 50-day moving average of €1.31 and way above its 200-day moving average of €1.23.
More news about AFFLUENT MEDICAL (AFME.PA).
